Lidings’ Managing Partner, Head of the pharmaceuticals and healthcare industry practice of the firm Andrey Zelenin will speak at the 25th Russian Pharmaceutical Forum annually organized in Saint Petersburg by the Adam Smith Institute with Lidings’ support. The jubilee event will take place on 14-15 of May 2019, traditionally hosted by one of the city’s central locations — Corinthia Hotel.
Regulating and controlling authorities, business’ representatives and legal counsels focused on advising companies from the pharmaceuticals sector will once again gather together to discuss current regulation of the Life Sciences industry including analysis of recent reforms and consideration of governmental initiatives aimed at stimulating the segment development.
Andrey Zelenin, a recognized expert in the field of advising pharmaceutical companies in Russia, will act as a moderator of a session dedicated to antimonopoly violations in pharma. In addition he will also make a special presentation on the Pricing in Pharmaceutical Market: New Trends Following Novartis Case.
Lidings is a leading legal advisor in Russia, acting as an expert in the statutory regulation of the pharmaceutical industry. The firm’s clients are recognized leaders of the pharmaceutical market, such as AstraZeneca, Boehringer Ingelheim, Merck, Ipsen Pharmaceuticals, Astellas Pharma, Mallinckrodt Pharmaceuticals, Mylan, Sanofi and many others. The firm frequently initiates and supports major international conferences devoted to issues most essential for the pharmaceutical industry in Russia and abroad. Lidings’ experts act as speakers and moderators in discussions on legal support of pharmaceutical companies doing business in the Russian Federation.
Adam Smith Pharmaceutical Forum is one of the largest international industry events taking place in Russia. The initiative traditionally attracts manufacturers, distributors and retail chains, as well as leading experts and CEOs of the largest pharmaceutical enterprises who attend the event to discuss topics essential for the industry.
To download the Forum’s program and find out more about the speakers, please refer to the official website.